Days-to-cover ratio for RLMD surges to 9.11 due to rise in short interest
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Relmada Therapeutics Inc shares valued at $109,752 were purchased by TRAVERSA SERGIO on Jan 31 ’24. At $4.00 per share, TRAVERSA SERGIO acquired 27,460 shares. The insider’s holdings grew to 244,024 shares worth approximately […]
